219 related articles for article (PubMed ID: 14686479)
21. Changes in erythrocyte enzymes in humans long-term exposed to pesticides: influence of several markers of individual susceptibility.
Hernández AF; López O; Rodrigo L; Gil F; Pena G; Serrano JL; Parrón T; Alvarez JC; Lorente JA; Pla A
Toxicol Lett; 2005 Oct; 159(1):13-21. PubMed ID: 15922524
[TBL] [Abstract][Full Text] [Related]
22. A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis.
Morahan JM; Yu B; Trent RJ; Pamphlett R
Neurotoxicology; 2007 May; 28(3):532-40. PubMed ID: 17204329
[TBL] [Abstract][Full Text] [Related]
23. 8-Hydroxydeoxyguanosine levels in human leukocyte and urine according to exposure to organophosphorus pesticides and paraoxonase 1 genotype.
Lee CH; Kamijima M; Kim H; Shibata E; Ueyama J; Suzuki T; Takagi K; Saito I; Gotoh M; Hibi H; Naito H; Nakajima T
Int Arch Occup Environ Health; 2007 Jan; 80(3):217-27. PubMed ID: 16915393
[TBL] [Abstract][Full Text] [Related]
24. Gene-environmental interactions and organophosphate toxicity.
Povey AC
Toxicology; 2010 Dec; 278(3):294-304. PubMed ID: 20156521
[TBL] [Abstract][Full Text] [Related]
25. High-density lipoprotein cholesterol and paraoxonase 1 (PON1) genetics and serum PON1 activity in prepubertal children in Spain.
Garcés C; López-Simón L; Rubio R; Benavente M; Cano B; Ortega H; de Oya M
Clin Chem Lab Med; 2008; 46(6):809-13. PubMed ID: 18601602
[TBL] [Abstract][Full Text] [Related]
26. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE
Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566
[TBL] [Abstract][Full Text] [Related]
27. Relationship between internal and external factors and the activity of PON1.
Del Carmen Xotlanihua-Gervacio M; Herrera-Moreno JF; Medina-Díaz IM; Bernal-Hernández YY; Rothenberg SJ; Barrón-Vivanco BS; Rojas-García AE
Environ Sci Pollut Res Int; 2019 Aug; 26(24):24946-24957. PubMed ID: 31243662
[TBL] [Abstract][Full Text] [Related]
28. Haplotype-phenotype relationships of paraoxonase-1.
Chen J; Chan W; Wallenstein S; Berkowitz G; Wetmur JG
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):731-4. PubMed ID: 15767359
[TBL] [Abstract][Full Text] [Related]
29. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
[TBL] [Abstract][Full Text] [Related]
30. Modulation of paraoxonase (PON1) activity.
Costa LG; Vitalone A; Cole TB; Furlong CE
Biochem Pharmacol; 2005 Feb; 69(4):541-50. PubMed ID: 15670573
[TBL] [Abstract][Full Text] [Related]
31. Paraoxonase status and plasma butyrylcholinesterase activity in chlorpyrifos manufacturing workers.
Albers JW; Garabrant DH; Berent S; Richardson RJ
J Expo Sci Environ Epidemiol; 2010 Jan; 20(1):79-89. PubMed ID: 19223938
[TBL] [Abstract][Full Text] [Related]
32. The Relationship between PON1 phenotype and PON1-192 genotype in detoxification of three oxons by human liver.
Mutch E; Daly AK; Williams FM
Drug Metab Dispos; 2007 Feb; 35(2):315-20. PubMed ID: 17132760
[TBL] [Abstract][Full Text] [Related]
33. Assessment of the role of paraoxonase gene polymorphism (Q192R) and paraoxonase activity in the susceptibility to atherosclerosis among lead-exposed workers.
Kamal M; Fathy MM; Taher E; Hasan M; Tolba M
Ann Saudi Med; 2011; 31(5):481-7. PubMed ID: 21911985
[TBL] [Abstract][Full Text] [Related]
34. Paraoxonase 1 and its relationship with pesticide biomarkers in indigenous Mexican farmworkers.
Bernal-Hernández YY; Medina-Díaz IM; Barrón-Vivanco BS; Robledo-Marenco Mde L; Girón-Pérez MI; Pérez-Herrera NE; Quintanilla-Vega B; Cerda-Flores R; Rojas-García AE
J Occup Environ Med; 2014 Mar; 56(3):281-90. PubMed ID: 24423702
[TBL] [Abstract][Full Text] [Related]
35. Distribution of paraoxonase-1 gene polymorphisms and enzyme activity in a Peruvian population.
Cataño HC; Cueva JL; Cardenas AM; Izaguirre V; Zavaleta AI; Carranza E; Hernández AF
Environ Mol Mutagen; 2006 Dec; 47(9):699-706. PubMed ID: 17078098
[TBL] [Abstract][Full Text] [Related]
36. In utero pesticide exposure, maternal paraoxonase activity, and head circumference.
Berkowitz GS; Wetmur JG; Birman-Deych E; Obel J; Lapinski RH; Godbold JH; Holzman IR; Wolff MS
Environ Health Perspect; 2004 Mar; 112(3):388-91. PubMed ID: 14998758
[TBL] [Abstract][Full Text] [Related]
37. The paraoxonase promoter polymorphism (-107)T>C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients.
Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Castaldo M; Fontana L; Bonaiuto A; Bitto A; Saitta C; Saitta A
Clin Biochem; 2004 May; 37(5):388-94. PubMed ID: 15087255
[TBL] [Abstract][Full Text] [Related]
38. Interethnic variability of plasma paraoxonase (PON1) activity towards organophosphates and PON1 polymorphisms among Asian populations--a short review.
Mohamed Ali S; Chia SE
Ind Health; 2008 Aug; 46(4):309-17. PubMed ID: 18716378
[TBL] [Abstract][Full Text] [Related]
39. Changes in antioxidant enzymes in humans with long-term exposure to pesticides.
López O; Hernández AF; Rodrigo L; Gil F; Pena G; Serrano JL; Parrón T; Villanueva E; Pla A
Toxicol Lett; 2007 Jul; 171(3):146-53. PubMed ID: 17590542
[TBL] [Abstract][Full Text] [Related]
40. Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds.
Li WF; Costa LG; Richter RJ; Hagen T; Shih DM; Tward A; Lusis AJ; Furlong CE
Pharmacogenetics; 2000 Dec; 10(9):767-79. PubMed ID: 11191881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
